Medical research

Study paves the way for an active agent against hepatitis E

At present, there is no specific active substance against hepatitis E. As the disease kills 70,000 people every year, researchers are actively searching for one. The team from the Department of Molecular and Medical Virology ...

Oncology & Cancer

Advances in multiple myeloma treatment

March is Myeloma Awareness Month. Multiple myeloma is a blood cancer that most often occurs in people over age 45. It's the second-most common blood cancer and the most common blood cancer in Black people.

page 1 from 37